The anatomic distribution of melanoma and relationships with childhood nevus distribution in colorado

Melanoma Research

Volumn 19, Issue 4, 2009, Pages 252-259

  Juhl, Ashley L ^a   Byers, Tim E ^a   Robinson, William A ^b   Morelli, Joseph G ^b   Crane, Lori A ^a  

^a Food Science and Human Nutrition   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Anatomic distribution; Epidemiology; Malignant melanoma; Melanocytic nevi

Indexed keywords

ADOLESCENT; ADULT; AGED; ARM; ARTICLE; CANCER LOCALIZATION; CANCER REGISTRY; CHILD; CHILDHOOD DISEASE; DISEASE ASSOCIATION; FEMALE; HEAD; HISPANIC; HISTOPATHOLOGY; HUMAN; LEG; MAJOR CLINICAL STUDY; MALE; MALIGNANT LENTIGO; MELANOMA; METASTASIS; NECK; NEVUS; PATHOLOGICAL ANATOMY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SKIN EXAMINATION; SUMMER; TRUNK; UNITED STATES;

ABDOMEN; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BODY SURFACE AREA; CHI-SQUARE DISTRIBUTION; CHILD; COHORT STUDIES; COLORADO; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; LOWER EXTREMITY; MALE; MELANOMA; MIDDLE AGED; REGISTRIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SEX CHARACTERISTICS; SKIN NEOPLASMS; UPPER EXTREMITY; YOUNG ADULT;

EID: 68949148924     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e32832e0b81     Document Type: Article

References (52)

1. Grob JJ, Gouvernet J, Aymar D, Mostaque A, Romano MH, Collet AM, et al. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer 1990; 66:387-395.
2. Green AC, MacLennan R, Siskind V. Common acquired nevi and the risk of malignant melanoma. Int J Cancer 1985; 35:297-300.
3. Skender-Kalnenas TM, English DR, Heenan PJ. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? J Am Acad Dermatol 1995; 33:1000-1007.
4. Langholz B, Richardson J, Rappaport E, Waisman J, Cockburn M, Mack T. Skin characteristics and risk of superficial spreading and nodular melanoma (United States). Cancer Causes Control 2000; 11:741-750.
5. Grulich AE, Bataille V, Swerdlow AJ, Newton-Bishop JA, Cuzick J, Hersey P, et al. Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia. Int J Cancer 1996; 67:485-491.
6. Gallagher RP, McLean DI, Yang CP, Coldman AJ, Silver HKB, Spinelli JJ, et al. Anatomic distribution of acquired melanocytic nevi in white children. A comparison with melanoma: the Vancouver Mole study. Arch Dermatol 1990; 126:466-471.
7. Autier P, Boniol M, Severi G, Pedeux R, Grivegnée AR, Dore JF, et al. Sex differences in numbers of nevi on body sites of young European children: implications for the etiology of cutaneous melanoma. Cancer Epidemiol Biomarkers Prev 2004; 13:2003-2005.
8. Weinstock MA, Colditz GA, Willett WC, Stampfer MJ, Bronstein BA, Mihm MC, et al. Nonfamilial cutaneous melanoma incidence in women associated with sun exposure before 20 years of age. Pediatrics 1989; 84:199-204.
9. Whiteman DC, Watt P, Purdie DM, Hughes MC, Hayward NK, Green AC. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 2003; 95:806-812.
10. Clark WH, Elder DE, Van Horn M. The biologic forms of malignant melanoma. Hum Pathol 1986; 17:443-450.
11. Purdue MP, From L, Armstrong BK, Kricker A, Gallagher RP, McLaughlin JR, etal. Etiologic and other factors predicting nevus-associated cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev 2005; 14:2015-2022.
12. Holman CDJ, Armstrong BK, Heenan PJ. Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst 1986; 76:403-414.
13. Chamberlain AJ, Fritschi L, Giles GG, Dowling JP, Kelly JW. Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. Arch Dermatol 2002; 138:609-614.
14. McGovern VJ, Shaw HM, Milton GW, Farago GA. Is malignant melanoma arising in a Hutchinson's melanotic freckle a separate disease entity? Histopathology 1980; 4:235-242.
15. Krüger S, Garbe C, Büttner P, Stadler R, Guggenmoos-Holzmann I, Orfanos CE. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. J Am Acad Dermatol 1992; 26:920-926.
16. Ródenas JM, Delgado-Rodr?́guez M, Farin̈as- Álvarez C, Herranz MT, Serrano S. Melanocytic nevi and risk of cutaneous malignant melanoma in Southern Spain. Am J Epidemiol 1997; 145:1020-1029.
17. Randi G, Naldi L, Gallus S, Di Landro A, La Vecchia C. Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma. J Invest Dermatol 2006; 126:2106-2110.
18. Rieger E, Soyer HP, Garbe C, Büttner P, Kofler R, Weiss J, et al. Overall and site-specific risk of malignant melanoma associated with nevus counts at different body sites: a multicenter case-control study of the German Central Malignant-Melanoma Registry. Int J Cancer 1995; 62:393-397.
19. Bauer J, Garbe C. Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological data. Pigment Cell Res 2003; 16:297-306.
20. Dennis LK, White E, Lee JAH, Kristal A, McKnight B, Odland P. Constitutional factors and sun exposure in relation to nevi: a population-based cross-sectional study. Am J Epidemiol 1996; 143:248-256.
21. Fritschi L, McHenry P, Green A, MacKie R, Green L, Siskind V. Naevi in schoolchildren in Scotland and Australia. Br J Dermatol 1994; 130:599-603.
22. Four Types of Melanoma [homepage on the Internet] Schaumburg: AAD; c2008 [updated 2008 March 4; cited 2008 March 27]. American Academy of Dermatology; [about 5 screens]. Available from: http://www.skincarephysicians.com/ skincancernet/four-types.html
23. Dodd AT, Morelli J, Mokrohisky ST, Asdigian N, Byers TE, Crane LA. Melanocytic nevi and sun exposure in a cohort of Colorado children: anatomic distribution and site-specific sunburn. Cancer Epidemiol Biomarkers Prev 2007; 16:2136-2143.
24. English DR, MacLennan R, Rivers J, Kelly J, Armstrong BK. Epidemiological studies of melanocytic naevi: protocol for identifying and recording naevi. J ARC internal report no. 90/002. Lyon: IARC; 1990.
25. Haley JC, Hood AF, Chuang TY, Rasmussen J. The frequency of histologically dysplastic nevi in 199 pediatric patients. Pediatr Dermatol 2000; 17:266-269.
26. Charman CR, Venn AJ, Williams HC. Measurement of body surface area involvement in atopic eczema: an impossible task? Br J Dermatol 1999; 140:109-111.
27. Boniol M, Verriest JP, Pedeux R, Dore JF. Proportion of skin surface area of children and young adults from 2 to 18 years old. J Invest Dermatol 2008; 128:461-464.
28. Decennial Census 2000 [homepage on the Internet]. Washington DC: US Census Bureau; c2008 [updated 2007 August 28; cited 2008 March 27]. American Fact Finder; [about 2 screens]. Available from: http://factfinder.census.gov/
29. Brewster DH, Horner MJD, Rowan S, Jelfs P, de Vries E, Pukkala E. Left-sided excess of invasive cutaneous melanoma in six countries. Eur J Cancer 2007; 43:2634-2637.
30. Bulliard JL, Ess S, Bordoni A, Konzelmann I, Levi F. Left-sided excess in the laterality of cutaneous melanoma. Arch Dermatol 2008; 144:556-558.
31. Brewster DH, de Vries E. Left-sided excess in the laterality of cutaneous melanoma. Arch Dermatol 2008; 144:1235.
32. Cress RD, Holly EA, Ahn DK, LeBoit PE, Sagebiel RW. Cutaneous melanoma in women: anatomic distribution in relation to sun exposure and phenotype. Cancer Epidemiol Biomarkers Prev 1995; 4:831-836.
33. Demierre MF, Chung C, Miller DR, Geller AC. Early detection of thick melanomas in the United States. Arch Dermatol 2005; 141:745-750.
34. Bergenmar M, Hansson J, Brandberg Y. Detection of nodular and superficial spreading melanoma with tumor thickness r 2.0 mm - an interview study. Eur J Cancer Prev 2002; 11:49-55.
35. Holman CD, Armstrong BK, Heenan PJ. A theory of the etiology and pathogenesis of human cutaneous malignant melanoma. J Natl Cancer Inst 1983; 71:651-656.
36. Swerdlow AJ, English J, MacKie RM, O'Doherty CJ, Hunter JAA, Clark J, et al. Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J 1986; 292:1555-1559.
37. Newell GR, Sider JG, Bergfelt L, Kripke ML. Incidence of cutaneous melanoma in the United States by histology with special reference to the face. Cancer Res 1988; 48:5036-5041.
38. Cox NH, Jones SK, MacKie RM. Malignant melanoma of the head and neck in Scotland: an eight-year analysis of trends in prevalence, distribution and prognosis. QJ Med 1987; 64:661-670.
39. Cohen LM. Lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol 1995; 33:923-936.
40. Green A, McCredie M, MacKie R, Giles G, Young P, Morton C, et al. A case-control study of melanomas of the soles and palms (Australia and Scotland). Cancer Causes Control 1999; 10:21-25.
41. Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005; 353:2135-2147.
42. Miller AJ, Mihm MC. Melanoma. N Engl J Med 2006; 355:51-65.
43. Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, et al. High frequency of BRAF mutations in nevi. Nat Genet 2003; 33:19-20.
44. Maldonado JL, Fridlyand J, Patel H, Jain AN, Busam KJ, Kageshita T, et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 2003; 95:1878-1880.
45. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, et al. SEER Cancer Statistics Review, 1975-2005 [monograph on the Internet]. Bethesda, MD: National Cancer Institute; c2008 [cited 2009 March 27]. Available from: http://seer.cancer.gov/csr/1975-2005/
46. Finch JL,Vu KO, Karp SK. Cancer in Colorado, 1992-2002: incidence and mortality by county [monograph on the Internet]. Denver, CO: Colorado Department of Public Health and Environment; c2005 [cited 2008 May 27]. Available from: http://www.cdphe.state.co.us/pp/cccr/cccrreports.html
47. Pope DJ, Sorahan T, Marsden JR, Ball PM, Grimley RP, Peck IM. Benign pigmented nevi in children. Prevalence and associated factors: the West Midlands, United Kingdom mole study. Arch Dermatol 1992; 128:1201-1206.
48. Graham A, Fuller A, Murphy M, Jones M, Forman D, Swerdlow AJ. Maternal and child constitutional factors and the frequency of melanocytic naevi in children. Paediatr Perinat Epidemiol 1999; 13:316-324.
49. Gallagher RP, Rivers JK, Lee TK, Bajdik CD, McLean DI, Coldman AJ. Broad-spectrum sunscreen use and the development of new nevi in white children: a randomized controlled trial. JAMA 2000; 283:2955-2960.
50. Valiukeviciene S, Miseviciene I, Gollnick H. The prevalence of common acquired melanocytic nevi and the relationship with skin type characteristics and sun exposure among children in Lithuania. Arch Dermatol 2005; 141:579-586.
51. Dal H, Boldemann C, Lindelof̈ B. Does relative melanoma distribution by body site 1960-2004 reflect changes in intermittent exposure and intentional tanning in the Swedish population? Eur J Dermatol 2007; 17:428-434.
52. La Vecchia C, Lucchini F, Negri E, Levi F. Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age. Int J Cancer 1999; 81:62-66.